Drug Combination Details
| General Information of the Combination (ID: C23002) | |||||
|---|---|---|---|---|---|
| Name | Resveratrol NP Info | + | Roscovitine Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vitro Model | MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | ||
| Experimental
Result(s) |
Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. | |||||
| References | ||||
|---|---|---|---|---|
| Reference 1 | Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. Food Chem Toxicol. 2008 Apr;46(4):1327-33. | |||
